Congenital bilateral ptosis, Congenital sensorineural hearing impairment, Decreased body weight, Delayed eruption of teeth, Delayed skeletal maturation, Failure to thrive, Hyperactivity, Hypoglycemia, Hypogonadism, Insulin resistance, Intellectual disability, Intellectual disability, mild, Intrauterine growth retardation, Low anterior hairline, Low posterior hairline, Microcephaly, Micrognathia, Motor delay, Myopia, Neonatal hyperbilirubinemia, Osteopenia, Osteoporosis, Prelingual sensorineural hearing impairment, Prominent forehead, Ptosis, Radial deviation of finger, Sensorineural hearing impairment, Severe intrauterine growth retardation, Severe postnatal growth retardation, Short attention span, Short stature, Single transverse palmar crease, Small for gestational age, Small placenta, Truncal obesity

abnormal mitral cell morphology, abnormal olfactory bulb external plexiform layer morphology, abnormal olfactory bulb layer morphology, abnormal olfactory bulb mitral cell layer morphology, abnormal otic capsule morphology, abnormal postnatal growth/weight/body size, abnormal sensory neuron innervation pattern, abnormal tectorial membrane morphology, cochlear ganglion degeneration, decreased birth weight, decreased body length, decreased body size, decreased circulating glucose level, decreased circulating growth hormone level, decreased circulating insulin-like growth factor I level, decreased kidney weight, decreased long bone epiphyseal plate size, decreased motor neuron number, decreased survivor rate, decreased tumor growth/size, decreased width of hypertrophic chondrocyte zone, delayed bone ossification, delayed endochondral bone ossification, delayed inner ear development, disproportionate dwarf, fetal growth retardation, growth/size/body region phenotype, hearing/vestibular/ear phenotype, homeostasis/metabolism phenotype, increased circulating growth hormone level, increased neuron apoptosis, increased or absent threshold for auditory brainstem response, increased systemic arterial blood pressure, increased systemic arterial diastolic blood pressure, increased systemic arterial systolic blood pressure, increased type II pneumocyte number, increased urine sodium level, increased ventricle muscle contractility, insensitivity to growth hormone, neonatal lethality, complete penetrance, neonatal lethality, incomplete penetrance, no abnormal phenotype detected, perinatal lethality, incomplete penetrance, postnatal lethality, incomplete penetrance, premature death, prenatal lethality, incomplete penetrance, primary atelectasis, proportional dwarf, renal/urinary system phenotype, reproductive system phenotype, sensorineural hearing loss, slow postnatal weight gain, small cochlear ganglion, syndromic hearing loss